Nanotechnology Now - Press Release: FINAL ANNOUNCEMENT: Medtech Insight and Windhover Information’s “Investment In Innovation (In3) West” Emerging Medical Technology Investment and Partn

Home > Press > FINAL ANNOUNCEMENT: Medtech Insight and Windhover Information’s “Investment In Innovation (In3) West” Emerging Medical Technology Investment and Partn

Abstract:
February 27-29, 2008, The Venetian, Las Vegas

FINAL ANNOUNCEMENT: Medtech Insight and Windhover Information’s “Investment In Innovation (In3) West” Emerging Medical Technology Investment and Partn

NEWPORT BEACH, CA | Posted on February 21st, 2008

Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that >50 promising early- to late-stage medical device companies seeking funding and/or strategic partnership are currently confirmed to present at its "Investment In Innovation (In3) West" conference, being held February 27-29 at The Venetian Resort-Hotel-Casino in Las Vegas, Nevada. The two-day In3 West event (www.windhover.com/in3west08) - the company's 29th In3 conference - will showcase a carefully selected group of innovative young medtech companies from around the world presenting (the majority for the first time on our stage) to an audience of 250+ senior business development and investment executives from the leading medical technology and healthcare investment firms from around the world, for purposes of raising funding or forming strategic partnerships.

Presentations from this group of cutting-edge, early- to late-stage companies will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few. The nearly-full program of presenters confirmed to date include: ACell, Advanced Headache Intervention, Angel Medical Systems, Ascension Technology, Bone Biologics, Cardiva Medical, Ceragenix Pharmaceuticals, Cohera Medical, CoreSpine Technologies, Crospon, CVAC Systems, Deca-Medics, eCardio Diagnostics, EMKinetics, HealthLink Europe, HemoBioTech, Infrared Sciences, Innovent Medical Solutions, Interventional and Surgical Innovations (presenting 4 technologies), Light Sciences Oncology, Med-Conduit, Micronics, Minnow Medical, mNemoscience, Moerae Matrix, Navigant Biotechnologies, Neomend, Nerites, Nesos Health, Novian Health, Ortho Kinematics, Photo Dynamic Therapy, PolyRemedy, Portland Orthopaedic, Provista Life Sciences, Seno Medical Instruments, STI Medical Systems, Sunshine Heart Company, ThermopeutiX, Tissue Genetics, Ultimate Spine, ValveXchange, VeinAid, Veran Medical, Victhom Human Bionics, Visualase, Vivoxid, Xylos Corporation, and Zassi Medical Evolutions.

The In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature a presenting company product exhibition/networking reception, a Buyers' Perspective panel discussion/case study titled "What Are Buyers Looking for in 2008?", a Venture Perspective panel discussion/case study, "Doing Innovative or Unconventional Deals," a workshop hosted by Medical Capital Advisors entitled "10 Things Every Medical Technology Entrepreneur Should Know," and much more.

Event co-sponsors include AdvaMed, Battelle, Boston Healthcare Associates, Business Wire, Curran International, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, Ronald Trahan Associates, and TATRC (financial contributor).

The In3 West attendee list includes a robust line-up of buy-side/investors. A sample of companies sending their teams include: 3M, Abbott Laboratories, Abbott Vascular, Aberdare Ventures, Advanced Technology Ventures, Angiotech Pharmaceuticals, AstraZeneca Pharmaceuticals LP, Aubrey Group, Inc., Baird Venture Partners, Baxter Healthcare Corporation, Becton Dickinson & Co., Boston Scientific Corporation, Cardinal Health, Cargill Ventures, Clarus Ventures, CMEA Ventures, Cook, Coronis Medical Ventures, Covidien, C.R. Bard, Inc., Edwards Lifesciences, Ethicon, Ethicon Endo-Surgery, Inc., ev3 Inc., Frazier Healthcare Ventures, Galen, Galleon Group, Hercules Technology Growth Capital, InterWest Partners, Johnson & Johnson Development Corp., Kimberly-Clark Health Care, Kobayashi Pharmaceuticals of America, Longitude Capital, MediTech Advisors, Medtronic, MedVenture Technology Corporation, Musculoskeletal Transplant Foundation, Numenor Ventures LLC, OCTANe, Olympus Medical, Pharos Capital Group, Prism Venture Partners, Prospect Venture Partners, Queensland BioCapital Funds, Sante Ventures, Silicon Valley Bank, Special Situations Life Sciences Fund, St. Jude Medical, Stryker, SV Life Sciences, SVB Capital, Synergy Life Science Partners, Synthes Spine, Teijin America, Teijin Pharma, Ltd., Teleflex, The Carlyle Group, The Integra Group, Third Rock Ventures, Thoratec, Trevi Health Ventures, Triathlon Medical Ventures, Venrock Associates, Viscogliosi & Company, and Western Technology Investment, among many others.

Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 7 years.

Visit www.medtechinsight.com/pastpresenters.html for a full list of previous Medtech Insight conference presenters and their technology descriptions. To read what past attendees and industry www.medtechinsight.com/in3success.html.

Three additional "Investment In Innovation" events will be held this year: In3 Europe will be held in Paris, April 29-30; the In3 Medical Device Summit will take place in San Francisco, June 17-19; and In3 East will be held October 22-24 in Boston. Visit www.medtechinsight.com/conferences.html for more information on these excellent investment and partnering events.

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.

www.medtechinsight.com
www.windhover.com

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: